Chinese Pharma Co. Gets Nasdaq Leeway Amid FCPA Probe
Chinese vaccine maker Sinovac Biotech Ltd. said Monday that Nasdaq has approved its plan stay listed in the U.S. and disclosed that the company is expanding an internal probe into potential...To view the full article, register now.
Already a subscriber? Click here to view full article